Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1922) 1922
Book Review (237) 237
Publication (203) 203
Book Chapter (14) 14
Conference Proceeding (9) 9
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1834) 1834
humans (1761) 1761
ophthalmology (1515) 1515
male (1296) 1296
female (1281) 1281
aged (1111) 1111
middle aged (951) 951
macular degeneration (933) 933
choroidal neovascularization - physiopathology (910) 910
fluorescein angiography (767) 767
visual acuity - physiology (758) 758
choroidal neovascularization (731) 731
aged, 80 and over (717) 717
choroidal neovascularization - drug therapy (617) 617
macular degeneration - physiopathology (604) 604
tomography, optical coherence (602) 602
treatment outcome (585) 585
photodynamic therapy (546) 546
retrospective studies (495) 495
ranibizumab (488) 488
follow-up studies (478) 478
vascular endothelial growth factor a - antagonists & inhibitors (476) 476
bevacizumab (462) 462
choroidal neovascularization - etiology (454) 454
visual acuity (441) 441
intravitreal injections (439) 439
angiogenesis inhibitors - therapeutic use (429) 429
adult (409) 409
age-related macular degeneration (397) 397
verteporfin (379) 379
prospective studies (356) 356
neovascularization (335) 335
photochemotherapy (318) 318
macular degeneration - complications (310) 310
macular degeneration - drug therapy (309) 309
angiogenesis inhibitors - administration & dosage (297) 297
antibodies, monoclonal, humanized (281) 281
animals (276) 276
endothelial growth-factor (276) 276
choroidal neovascularization - diagnosis (272) 272
eye diseases (272) 272
optical coherence tomography (249) 249
physiological aspects (240) 240
vascular endothelial growth factor (240) 240
wet macular degeneration - physiopathology (227) 227
care and treatment (211) 211
choroid - blood supply (205) 205
injections (202) 202
abridged index medicus (198) 198
vitreous body (192) 192
photosensitizing agents - therapeutic use (191) 191
porphyrins - therapeutic use (189) 189
wet macular degeneration - drug therapy (188) 188
subfoveal choroidal neovascularization (187) 187
retina (183) 183
antibodies, monoclonal - administration & dosage (179) 179
age (178) 178
diabetic retinopathy (171) 171
genetic structures (170) 170
sense organs (170) 170
medical imaging (167) 167
medicine & public health (162) 162
fundus oculi (160) 160
retina - pathology (158) 158
antibodies, monoclonal, humanized - therapeutic use (155) 155
indocyanine green (153) 153
visual acuity - drug effects (151) 151
analysis (144) 144
research (138) 138
angiogenesis (133) 133
antibodies, monoclonal - therapeutic use (133) 133
mice (132) 132
time factors (131) 131
degeneration (129) 129
injection (126) 126
avastin (123) 123
secondary (123) 123
retreatment (121) 121
intravitreal bevacizumab (120) 120
retina - physiopathology (120) 120
eye (119) 119
polypoidal choroidal vasculopathy (117) 117
antibodies, monoclonal, humanized - administration & dosage (116) 116
maculopathy (116) 116
risk factors (114) 114
myopia (113) 113
therapy (113) 113
randomized clinical-trial (112) 112
coloring agents (110) 110
eyes (110) 110
prognosis (109) 109
choroidal neovascularization - pathology (108) 108
macular degeneration - diagnosis (108) 108
studies (108) 108
wet macular degeneration - diagnosis (108) 108
disease models, animal (106) 106
pathological myopia (106) 106
prevalence (105) 105
myopia, degenerative - physiopathology (104) 104
patients (104) 104
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1861) 1861
German (15) 15
Russian (12) 12
French (11) 11
Czech (6) 6
Japanese (6) 6
Romanian (4) 4
Polish (3) 3
Portuguese (2) 2
Chinese (1) 1
Hungarian (1) 1
Serbian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Quantitative Optical Coherence Tomography Angiography of Choroidal Neovascularization in Age-Related Macular Degeneration
by Jia, Yali, PhD and Bailey, Steven T., MD and Wilson, David J., MD and Tan, Ou, PhD and Klein, Michael L., MD and Flaxel, Christina J., MD and Potsaid, Benjamin, PhD and Liu, Jonathan J., MS and Lu, Chen D., MS and Kraus, Martin F., MS and Fujimoto, James G., PhD and Huang, David, MD, PhD
Ophthalmology, ISSN 0161-6420, 2014, Volume 121, Issue 7, pp. 1435 - 1444
Purpose To detect and quantify choroidal neovascularization (CNV) in patients with age-related macular degeneration (AMD) using optical coherence tomography... 
Ophthalmology | AMPLITUDE-DECORRELATION ANGIOGRAPHY | MOTION-CORRECTION | DISEASES | MICROVASCULATURE | LASER-DOPPLER FLOWMETRY | DOMAIN OCT | OPHTHALMOLOGY | MICROCIRCULATION | RETINAL BLOOD-FLOW | INDOCYANINE GREEN ANGIOGRAPHY | SWEPT-SOURCE | Choroidal Neovascularization - diagnosis | Cross-Sectional Studies | Tomography, Optical Coherence | Humans | Male | Wet Macular Degeneration - physiopathology | Healthy Volunteers | Choroidal Neovascularization - physiopathology | Wet Macular Degeneration - diagnosis | Pilot Projects | Algorithms | Blood Flow Velocity | Aged, 80 and over | Female | Aged | Imaging, Three-Dimensional | Fluorescein Angiography | Macular degeneration | Electrical engineering | Computer science | Tomography | Neovascularization | Angiography | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Intravitreal aflibercept injection in patients with myopic choroidal neovascularization: The MYRROR study
by Ikuno, Yasushi and Ohno-Matsui, Kyoko and Wong, Tien Yin and Korobelnik, Jean-Francois and Vitti, Robert and Li, Tummy and Stemper, Brigitte and Asmus, Friedrich and Zeitz, Oliver and Ishibashi, Tatsuro and MYRROR Investigators
Ophthalmology, ISSN 0161-6420, 06/2015, Volume 122, Issue 6, pp. 1220 - 1227
Purpose To evaluate intravitreal aflibercept 2 mg in patients with myopic choroidal neovascularization (CNV). Design An international, phase III, multicenter,... 
POPULATION | MACULAR EDEMA SECONDARY | BEVACIZUMAB | PATHOLOGICAL MYOPIA | OPHTHALMOLOGY | PREVALENCE | OUTCOMES | VEGF TRAP-EYE | RANIBIZUMAB | Receptors, Vascular Endothelial Growth Factor - therapeutic use | Double-Blind Method | Intravitreal Injections | Tomography, Optical Coherence | Humans | Middle Aged | Recombinant Fusion Proteins - therapeutic use | Choroidal Neovascularization - etiology | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Choroidal Neovascularization - physiopathology | Myopia, Degenerative - drug therapy | Choroidal Neovascularization - drug therapy | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Aged | Myopia, Degenerative - complications | Visual Acuity - physiology | Myopia, Degenerative - physiopathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Randomized Trial of a Home Monitoring System for Early Detection of Choroidal Neovascularization Home Monitoring of the Eye (HOME) Study
by Chew, Emily Y., MD and Clemons, Traci E., PhD and Bressler, Susan B., MD and Elman, Michael J., MD and Danis, Ronald P., MD and Domalpally, Amitha, MD and Heier, Jeffrey S., MD and Kim, Judy E., MD and Garfinkel, Richard, MD and AREDS2 HOME Study Res Grp and AREDS2-HOME Study Research Group
Ophthalmology, ISSN 0161-6420, 2014, Volume 121, Issue 2, pp. 535 - 544
Objective To determine whether home monitoring with the ForeseeHome device (Notal Vision Ltd, Tel Aviv, Israel), using macular visual field testing with... 
Ophthalmology | PREFERENTIAL HYPERACUITY PERIMETER | MULTICENTER | BEVACIZUMAB | OPHTHALMOLOGY | MACULAR DEGENERATION | SUBGROUP ANALYSIS | RANIBIZUMAB | Visual Fields - physiology | Choroidal Neovascularization - diagnosis | Prospective Studies | Monitoring, Ambulatory - methods | Tomography, Optical Coherence | Humans | Middle Aged | Male | Choroidal Neovascularization - physiopathology | Disease Progression | Vision Disorders - diagnosis | Vision Disorders - physiopathology | Telemedicine - methods | Aged, 80 and over | Female | Aged | Visual Field Tests - instrumentation | Visual Acuity - physiology | Fluorescein Angiography | Macular degeneration | Medical colleges | Continuing medical education | Analysis | Clinical trials | Eye diseases | Neovascularization | Vascular endothelial growth factor | Consulting services | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Association of Choroidal Neovascularization and Central Serous Chorioretinopathy With Optical Coherence Tomography Angiography
by Bonini Filho, Marco Antonio and de Carlo, Talisa E and Ferrara, Daniela and Adhi, Mehreen and Baumal, Caroline R and Witkin, Andre J and Reichel, Elias and Duker, Jay S and Waheed, Nadia K
JAMA Ophthalmology, ISSN 2168-6165, 08/2015, Volume 133, Issue 8, pp. 899 - 906
IMPORTANCE: Choroidal neovascularization (CNV) is a major cause of vision loss in chronic central serous chorioretinopathy (CSCR). Detecting CNV using... 
PHOTODYNAMIC THERAPY | OPHTHALMOLOGY | Choroidal Neovascularization - diagnosis | Prospective Studies | Cross-Sectional Studies | Tomography, Optical Coherence | Humans | Middle Aged | Male | Choroidal Neovascularization - physiopathology | Central Serous Chorioretinopathy - diagnosis | Retinal Detachment - diagnosis | Sensitivity and Specificity | Adult | Female | Central Serous Chorioretinopathy - physiopathology | Visual Acuity - physiology | Fluorescein Angiography | Vision disorders | Usage | Care and treatment | Fluorescence angiography | Risk factors | Uveitis | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text HORIZON: An Open-Label Extension Trial of Ranibizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
by Singer, Michael A., MD and Awh, Carl C., MD and Sadda, SriniVas, MD and Freeman, William R., MD and Antoszyk, Andrew N., MD and Wong, Pamela, MPH and Tuomi, Lisa, PharmD
Ophthalmology, ISSN 0161-6420, 2012, Volume 119, Issue 6, pp. 1175 - 1183
Objective To evaluate the long-term safety and efficacy of multiple intravitreal ranibizumab injections (Lucentis, Genentech, Inc., South San Francisco, CA)... 
Ophthalmology | OPHTHALMOLOGY | VERTEPORFIN PHOTODYNAMIC THERAPY | Antibodies, Monoclonal, Humanized - adverse effects | Follow-Up Studies | Intravitreal Injections | Macular Degeneration - physiopathology | Humans | Macular Degeneration - complications | Choroidal Neovascularization - etiology | Male | Treatment Outcome | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Choroidal Neovascularization - physiopathology | Macular Degeneration - drug therapy | Angiogenesis Inhibitors - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Choroidal Neovascularization - drug therapy | Ranibizumab | Female | Aged | Angiogenesis Inhibitors - adverse effects | Visual Acuity - physiology | Macular degeneration | Physiological aspects | Neovascularization | Singers | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Choroidal Neovascularization
by Spaide, Richard F
Retina, ISSN 0275-004X, 02/2017, Volume 37, Issue 4, pp. 609 - 610
OPHTHALMOLOGY | RANIBIZUMAB | Choroidal Neovascularization - diagnosis | Choroidal Neovascularization - drug therapy | Fluorescein Angiography - methods | Humans | Choroid - blood supply | Angiogenesis Inhibitors - therapeutic use | Tomography, Optical Coherence - methods | Visual Acuity | Choroid - pathology | Fundus Oculi | Choroidal Neovascularization - physiopathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text LONGITUDINAL OPTICAL COHERENCE TOMOGRAPHY–ANGIOGRAPHY STUDY OF TYPE 2 NAIVE CHOROIDAL NEOVASCULARIZATION EARLY RESPONSE AFTER TREATMENT
by Lumbroso, Bruno and Rispoli, Marco and Savastano, Maria Cristina
Retina, ISSN 0275-004X, 10/2015, Volume 35, Issue 11, pp. 2242 - 2251
Purpose: To assess the longitudinal development of choroidal neovascularization (CNV) Type 2 after intravitreal anti-vascular endothelial growth factor by... 
Split-spectrum amplitude-decorrelation angiography | OCT angiography | Choroidal neovascularization type 2 | OPHTHALMOLOGY | choroidal neovascularization Type 2 | split-spectrum amplitude-decorrelation angiography | Choroidal Neovascularization - diagnosis | Follow-Up Studies | Intravitreal Injections | Macular Degeneration - physiopathology | Tomography, Optical Coherence | Humans | Middle Aged | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Choroidal Neovascularization - physiopathology | Macular Degeneration - diagnosis | Macular Degeneration - drug therapy | Choroiditis - diagnosis | Choroidal Neovascularization - drug therapy | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Female | Aged | Fluorescein Angiography | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text OCT angiography and sequential quantitative analysis of type 2 neovascularization after ranibizumab therapy
by Kuehlewein, L and Sadda, S.R and Sarraf, D
Eye (Basingstoke), ISSN 0950-222X, 07/2015, Volume 29, Issue 7, pp. 932 - 935
Purpose To study the precise structural aspects of a type 2 neovascular membrane in a patient with age-related macular degeneration (AMD) using optical... 
OPHTHALMOLOGY | MACULAR DEGENERATION | MOTION CORRECTION | CHOROIDAL NEOVASCULARIZATION | OPTICAL COHERENCE TOMOGRAPHY | Retinal Hemorrhage - physiopathology | Choroidal Neovascularization - diagnosis | Intravitreal Injections | Tomography, Optical Coherence | Humans | Male | Wet Macular Degeneration - physiopathology | Ranibizumab - therapeutic use | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Visual Acuity | Choroidal Neovascularization - physiopathology | Wet Macular Degeneration - diagnosis | Retinal Hemorrhage - diagnosis | Wet Macular Degeneration - drug therapy | Choroidal Neovascularization - drug therapy | Subretinal Fluid | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Aged | Retinal Hemorrhage - drug therapy | Fluorescein Angiography | Index Medicus | Clinical Study
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: Twelve-month MONT BLANC study results
by Larsen, Michael and Schmidt-Erfurth, Ursula and Lanzetta, Paolo and Wolf, Sebastian and Simader, Christian and Tokaji, Erika and Pilz, Stefan and Weisberger, Annemarie and MONT BLANC Study Grp and MONT BLANC Study Group
Ophthalmology, ISSN 0161-6420, 05/2012, Volume 119, Issue 5, pp. 992 - 1000
Purpose: To compare the efficacy and safety of same-day verteporfin photodynamic therapy (PDT) and intravitreal ranibizumab combination treatment versus... 
FACTOR VEGF | OCCULT | PHOTODYNAMIC THERAPY | EFFICACY | OPHTHALMOLOGY | DOSING REGIMEN | RANDOMIZED CLINICAL-TRIALS | ENDOTHELIAL GROWTH-FACTOR | Prospective Studies | Photosensitizing Agents - therapeutic use | Humans | Middle Aged | Male | Photosensitizing Agents - adverse effects | Photochemotherapy | Macular Degeneration - drug therapy | Incidence | Choroidal Neovascularization - drug therapy | Ranibizumab | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Female | Angiogenesis Inhibitors - adverse effects | Visual Acuity - physiology | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Porphyrins - therapeutic use | Double-Blind Method | Macular Degeneration - physiopathology | Treatment Outcome | Combined Modality Therapy | Choroidal Neovascularization - physiopathology | Porphyrins - adverse effects | Aged | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Comparison between spectral-domain and swept-source optical coherence tomography angiographic imaging of choroidal neovascularization
by Miller, Andrew R and Roisman, Luiz and Zhang, Qinqin and Zheng, Fang and Rafael de Oliveira Dias, Joao and Yehoshua, Zohar and Schaal, Karen B and Feuer, William and Gregori, Giovanni and Chu, Zhongdi and Chen, Chieh-Li and Kubach, Sophie and An, Lin and Stetson, Paul F and Durbin, Mary K and Wang, Ruikang K and Rosenfeld, Philip J
Investigative Ophthalmology and Visual Science, ISSN 0146-0404, 03/2017, Volume 58, Issue 3, pp. 1499 - 1505
PURPOSE. The purpose of this study was to compare imaging of choroidal neovascularization (CNV) using swept-source (SS) and spectral-domain (SD) optical... 
Swept-source OCTA | Neovascular AMD | Choroidal neovascularization | Optical coherence tomography angiography | Spectral-domain OCTA | OCTA | swept-source OCTA | choroidal neovascularization | optical coherence tomography angiography | OCT ANGIOGRAPHY | spectral-domain OCTA | TYPE-3 NEOVASCULARIZATION | OPHTHALMOLOGY | MACULAR DEGENERATION | neovascular AMD | Reproducibility of Results | Prospective Studies | Fluorescein Angiography - methods | Humans | Middle Aged | Choroid - blood supply | Male | Tomography, Optical Coherence - methods | Visual Acuity | Choroidal Neovascularization - physiopathology | Choroidal Neovascularization - pathology | Aged, 80 and over | Female | Aged | Choroid - pathology | Fundus Oculi | Index Medicus | Retina
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: Twelve-month results of the DENALI study
by Kaiser, Peter K and Boyer, David S and Cruess, Alan F and Slakter, Jason S and Pilz, Stefan and Weisberger, Annemarie and DENALI Study Grp and DENALI Study Group
Ophthalmology, ISSN 0161-6420, 05/2012, Volume 119, Issue 5, pp. 1001 - 1010
Purpose: To demonstrate noninferiority of ranibizumab in combination with verteporfin photodynamic therapy (PDT) versus ranibizumab monotherapy in patients... 
OPHTHALMOLOGY | TAP | DOSING REGIMEN | PHOTODYNAMIC THERAPY | RANDOMIZED CLINICAL-TRIAL | ENDOTHELIAL GROWTH-FACTOR | Prospective Studies | Photosensitizing Agents - therapeutic use | Humans | Middle Aged | Male | Photosensitizing Agents - adverse effects | Photochemotherapy | Macular Degeneration - drug therapy | Incidence | Choroidal Neovascularization - drug therapy | Ranibizumab | Angiogenesis Inhibitors - therapeutic use | Female | Angiogenesis Inhibitors - adverse effects | Visual Acuity - physiology | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Porphyrins - therapeutic use | Double-Blind Method | Macular Degeneration - physiopathology | Treatment Outcome | Combined Modality Therapy | Choroidal Neovascularization - physiopathology | Porphyrins - adverse effects | Aged | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Myopic choroidal neovascularization: A 10-year follow-up
by Yoshida, Takeshi and Ohno-Matsui, Kyoko and Yasuzumi, Kenjiro and Kojima, Ariko and Shimada, Noriaki and Futagami, Soh and Tokoro, Takashi and Mochizuki, Manabu
Ophthalmology, ISSN 0161-6420, 2003, Volume 110, Issue 7, pp. 1297 - 1305
Purpose: To clarify the long-term visual outcome of choroidal neovascularization (CNV) in eyes with high myopia in Asian patients. Design: We reviewed the... 
ANGIOID STREAKS | SURGERY | FOVEAL TRANSLOCATION | DEGENERATIVE MYOPIA | PHOTODYNAMIC THERAPY | PATHOLOGICAL MYOPIA | MEMBRANES | OPHTHALMOLOGY | LASER PHOTOCOAGULATION | SURGICAL REMOVAL | AGE | Myopia - complications | Choroidal Neovascularization - diagnosis | Prognosis | Follow-Up Studies | Humans | Middle Aged | Choroidal Neovascularization - etiology | Male | Choroidal Neovascularization - physiopathology | Atrophy | Vision Disorders - diagnosis | Vision Disorders - physiopathology | Myopia - physiopathology | Myopia - diagnosis | Adult | Female | Choroid - pathology | Retina - pathology | Visual Acuity - physiology | Fluorescein Angiography | Vision Disorders - etiology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF TIME COURSE OF CHOROIDAL NEOVASCULARIZATION IN RESPONSE TO ANTI-ANGIOGENIC TREATMENT
by Huang, David and Jia, Yali and Rispoli, Marco and Tan, O and Lumbroso, Bruno
Retina, ISSN 0275-004X, 10/2015, Volume 35, Issue 11, pp. 2260 - 2264
Purpose: To use optical coherence tomography (OCT) angiography to monitor the short-term blood flow changes in choroidal neovascularization (CNV) in response... 
Macula | Retina | Neovascularization | Optical coherence tomography angiography | Imaging | retina | BEVACIZUMAB | optical coherence tomography angiography | neovascularization | OPHTHALMOLOGY | MACULAR DEGENERATION | imaging | RANIBIZUMAB | macula | Receptors, Vascular Endothelial Growth Factor - therapeutic use | Intravitreal Injections | Tomography, Optical Coherence | Humans | Recombinant Fusion Proteins - therapeutic use | Choroid - blood supply | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Regional Blood Flow | Choroidal Neovascularization - physiopathology | Choroidal Neovascularization - drug therapy | Time Factors | Blood Flow Velocity | Angiogenesis Inhibitors - therapeutic use | Female | Aged | Retrospective Studies | Fluorescein Angiography | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Cytochrome P450 Oxidase 2C Inhibition Adds to ω-3 Long-Chain Polyunsaturated Fatty Acids Protection Against Retinal and Choroidal Neovascularization
by Gong, Yan and Fu, Zhongjie and Edin, Matthew L and Liu, Chi-Hsiu and Wang, Zhongxiao and Shao, Zhuo and Fredrick, Thomas W and Saba, Nicholas J and Morss, Peyton C and Burnim, Samuel B and Meng, Steven S and Lih, Fred B and Lee, Kin Sing Stephen and Moran, Elizabeth P and SanGiovanni, John Paul and Hellström, Ann and Hammock, Bruce D and Zeldin, Darryl C and Smith, Lois E.H
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 09/2016, Volume 36, Issue 9, pp. 1919 - 1927
OBJECTIVE—Pathological ocular neovascularization is a major cause of blindness. Increased dietary intake of ω-3 long-chain polyunsaturated fatty acids (LCPUFA)... 
Diabetic retinopathy | Choroidal neovascularization | Arachidonic acid | Docosahexaenoic acid | CYP2C inhibitor | Neovascularization, Physiologic - drug effects | Humans | Retinopathy of Prematurity - genetics | Quinolines - pharmacology | Retinopathy of Prematurity - physiopathology | Fatty Acids, Omega-3 - pharmacology | Lasers | Hyperoxia - complications | Retinopathy of Prematurity - enzymology | Retinal Neovascularization - enzymology | Retinal Neovascularization - prevention & control | Retinal Neovascularization - genetics | Cytochrome P-450 CYP2C8 - metabolism | Aorta - enzymology | Disease Models, Animal | Cytochrome P-450 CYP2C8 Inhibitors - pharmacology | Fatty Acids, Omega-3 - metabolism | Tissue Culture Techniques | Aorta - drug effects | Mice, Inbred C57BL | Cells, Cultured | Choroidal Neovascularization - enzymology | Angiogenesis Inhibitors - pharmacology | Genotype | Mice, Transgenic | Choroidal Neovascularization - prevention & control | Choroidal Neovascularization - physiopathology | Phenotype | Animals | Retinopathy of Prematurity - prevention & control | Acetates - pharmacology | Cytochrome P-450 CYP2C8 - genetics | Retinal Neovascularization - physiopathology | Choroidal Neovascularization - genetics | Endothelial Cells - enzymology | Endothelial Cells - drug effects | Index Medicus | pathological angiogenesis | ω-3 LCPUFA
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration
by Avery, Robert L and Pieramici, Dante J and Rabena, Melvin D and Castellarin, Alessandro A and Nasir, Ma’an A and Giust, Matthew J
Ophthalmology, ISSN 0161-6420, 2006, Volume 113, Issue 3, pp. 363 - 372.e5
To report the short-term safety, biologic effect, and a possible mechanism of action of intravitreal bevacizumab in patients with neovascular age-related... 
VERTEPORFIN | TISSUE-PLASMINOGEN ACTIVATOR | PHOTODYNAMIC THERAPY | PHARMACOKINETICS | FACTOR ANTIBODY FRAGMENT | INJECTION | COHERENCE TOMOGRAPHY FINDINGS | DISEASE | OPHTHALMOLOGY | ENDOTHELIAL GROWTH-FACTOR | SUBFOVEAL CHOROIDAL NEOVASCULARIZATION | Retina - drug effects | Choroidal Neovascularization - diagnosis | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Choroidal Neovascularization - etiology | Male | Retinal Detachment - drug therapy | Macular Degeneration - diagnosis | Macular Degeneration - drug therapy | Bevacizumab | Antibodies, Monoclonal, Humanized | Choroidal Neovascularization - drug therapy | Retinal Detachment - diagnosis | Aged, 80 and over | Vitreous Body | Female | Retrospective Studies | Antibodies, Monoclonal - immunology | Fluorescein Angiography | Macular Degeneration - physiopathology | Tomography, Optical Coherence | Fovea Centralis | Macular Degeneration - complications | Vascular Endothelial Growth Factor A - immunology | Visual Acuity | Choroidal Neovascularization - physiopathology | Pigment Epithelium of Eye | Injections | Antibodies, Monoclonal - administration & dosage | Papilledema - diagnosis | Aged | Retina - pathology | Papilledema - drug therapy | Macular degeneration | Physiological aspects | Eye diseases | Angiogenesis inhibitors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text "treat and extend" dosing of intravitreal antivascular endothelial growth factor therapy for type 3 neovascularization/retinal angiomatous proliferation
by Engelbert, Michael and Zweifel, Sandrine A and Freund, K Bailey
Retina, ISSN 0275-004X, 11/2009, Volume 29, Issue 10, pp. 1424 - 1431
Purpose: The purpose of this study was to analyze long-term outcomes for the treatment of type 3 neovascularization/retinal angiomatous proliferation using a... 
RAP | PHOTODYNAMIC THERAPY | MACULAR DEGENERATION | SURGICAL ABLATION | BEVACIZUMAB AVASTIN | DETACHMENT | CHOROIDAL NEOVASCULARIZATION | ranibizumab | type 3 neovascularization | lucentis | VERTEPORFIN | retinal angiomatous proliferation | avastin | bevacizumab | OPHTHALMOLOGY | TRIAMCINOLONE | Treat and Extend | CHORIORETINAL ANASTOMOSES | Choroidal Neovascularization - diagnosis | Humans | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Macular Degeneration - diagnosis | Macular Degeneration - drug therapy | Bevacizumab | Antibodies, Monoclonal, Humanized | Angiogenesis Inhibitors - administration & dosage | Choroidal Neovascularization - drug therapy | Ranibizumab | Aged, 80 and over | Vitreous Body | Female | Retrospective Studies | Visual Acuity - physiology | Fluorescein Angiography | Retinal Neovascularization - diagnosis | Macular Degeneration - physiopathology | Tomography, Optical Coherence | Treatment Outcome | Choroidal Neovascularization - physiopathology | Injections | Antibodies, Monoclonal - administration & dosage | Aged | Retinal Neovascularization - drug therapy | Retinal Neovascularization - physiopathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights